Navigation Links
Zombie cancer cells eat themselves to live
Date:4/5/2014

A University of Colorado Cancer Center study recently published in the journal Cell Reports and presented today at the American Association for Cancer Research (AACR) Annual Conference 2014 shows that the cellular process of autophagy in which cells "eat" parts of themselves in times of stress may allow cancer cells to recover and divide rather than die when faced with chemotherapies.

Autophagy, from the Greek "to eat oneself," is a process of cellular recycling in which cell organelles called autophagosomes encapsulate extra or dangerous material and transport it to the cell's lysosomes for disposable. Like tearing apart a Lego kit, autophagy breaks down unneeded cellular components into building blocks of energy or proteins for use in surviving times of low energy or staying safe from poisons and pathogens (among other uses).

"What we showed is that if this mechanism doesn't work right, for example if autophagy is too high or if the target regulated by autophagy isn't around, cancer cells may be able to rescue themselves from death caused by chemotherapies," says Andrew Thorburn, PhD, deputy director of the CU Cancer Center.

A movie that accompanies the study online shows a cancer cell dying. In the first few frames, mitochondrial cell walls break down and the cell's mitochondria can be seen releasing proteins in a process abbreviated as MOMP, which is considered a common marker of cell death. But then high autophagy allows the cell to encapsulate and "digest" these released proteins before MOMP can keep the cell well and truly dead. Later in the movie, the cancer cell recovers and goes on to divide.

"The implication here is that if you inhibit autophagy you'd make this less likely to happen, i.e. when you kill cancer cells they would stay dead," Thorburn says.

Thorburn and colleagues including postdoctoral researcher Jacob Gump, PhD, show that autophagy depends on the target PUMA to regulate cell death. Specifically, when PUMA is absent, it doesn't matter if autophagy is inhibited because without the communicating action of PUMA, cancer cells continue to survive.

The finding has important implications. First, it demonstrates a mechanism whereby autophagy controls cell death. And second, the study further reinforces the clinical potential of inhibiting autophagy to sensitize cancer cells to chemotherapy.

"Autophagy is complex and as yet not fully understood," Thorburn says. "But now that we see a molecular mechanism whereby cell-fate can be determined by autophagy, we hope to discover patient populations that could benefit from drugs that inhibit this action."


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. Want to survive the zombie apocalypse? This cologne could be the key (video)
2. Sleep may stop chronic pain sufferers from becoming zombies
3. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
4. Embryonic development protein active in cancer growth
5. BRG1 mutations confer resistance to hormones in lung cancer
6. Genetic variation in East Asians found to explain resistance to cancer drugs
7. Beyond the microscope: Identifying specific cancers using molecular analysis
8. Marshall University study may lead to new treatments for prostate cancer
9. Salk scientists open new window into how cancers override cellular growth controls
10. Penn research points to new way of preserving fertility for boys undergoing cancer treatment
11. Genetic abnormality offers diagnostic hope for childrens cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... ... 2017 , ... Vixiar Medical announced today that it will ... The LaunchPort™ Accelerator at the City Garage in Port Covington. The LaunchPort™, and ... services to its Residents. , Vixiar Medical recently closed a $1.5 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... sector professionals, has announced the addition of 5 new courses to its prospectus. ... Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures ...
(Date:9/20/2017)... ... 20, 2017 , ... Cybrexa Therapeutics , a start-up ... role of chief scientific officer. In this role, Dr. Paralkar will lead the ... CEO, Per Hellsund. , “I was impressed with Cybrexa’s revolutionary technology and excellent ...
(Date:9/20/2017)... ... 20, 2017 , ... From industry leaders, sports stars, and Hollywood icons to ... of these people had lost all hope. Their stories are told here. ... , “Neil takes readers on a riveting journey through the past, present ...
Breaking Biology Technology: